IL17A and Alzheimer disease: IL-17A decreases during the progression of AD from acute to chronic forms; triggers the production of IL-4 by Th2 cells; detected in acute AD lesions; number of peripheral blood IL-17+ CD4+ T cells correlated with disease severity; stimulates eosinophils to produce profibrotic cytokines